MYLAN 233 Pill - yellow capsule/oblong, 21mm
Pill with imprint MYLAN 233 is Yellow, Capsule/Oblong and has been identified as Efavirenz 600 mg. It is supplied by Mylan Pharmaceuticals Inc.
Efavirenz is used in the treatment of HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 233
Efavirenz
- Imprint
- MYLAN 233
- Strength
- 600 mg
- Color
- Yellow
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2233 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about efavirenz
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.